Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?

[1]  M. Whooley,et al.  Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  A. Anarat,et al.  The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[3]  F. Schaefer,et al.  Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  M. Kemper,et al.  Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. , 2010, Kidney international.

[5]  S. Goldstein,et al.  Malnutrition‐inflammation‐coronary calcification in pediatric patients receiving chronic hemodialysis , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[6]  R. Shroff,et al.  The virtues of vitamin D—but how much is too much? , 2010, Pediatric Nephrology.

[7]  C. Mathieu,et al.  Vitamin D insufficiency: implications for the immune system , 2010, Pediatric Nephrology.

[8]  D. Geary,et al.  Interventions for bone disease in children with chronic kidney disease. , 2010, The Cochrane database of systematic reviews.

[9]  L. Schurgers,et al.  Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. , 2010, Journal of the American Society of Nephrology : JASN.

[10]  M. Kuro-o.  Overview of the FGF23-Klotho axis , 2010, Pediatric Nephrology.

[11]  R. Shroff,et al.  Phosphate binders in CKD: chalking out the differences , 2010, Pediatric nephrology (Berlin, West).

[12]  A. Duzova,et al.  Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  A. Szabó,et al.  Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure , 2009, Pediatric Nephrology.

[14]  C. McKay,et al.  Emerging topics in pediatric bone and mineral disorders 2008. , 2009, Seminars in nephrology.

[15]  R. Elashoff,et al.  Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols , 2009, Pediatric Nephrology.

[16]  Thomas J. Wang,et al.  Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease , 2009, Circulation.

[17]  A. Hutchison.  Oral phosphate binders. , 2009, Kidney international.

[18]  D. Prié,et al.  Latest findings in phosphate homeostasis. , 2009, Kidney international.

[19]  S. Kuruğoğlu,et al.  Progression of coronary calcification in pediatric chronic kidney disease stage 5 , 2009, Pediatric Nephrology.

[20]  R. Shroff.  Monitoring Cardiovascular Risk Factors in Children on Dialysis , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[21]  R. Elashoff,et al.  Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. , 2009, The Journal of clinical endocrinology and metabolism.

[22]  M. Wolf,et al.  Phosphorus binders and survival on hemodialysis. , 2009, Journal of the American Society of Nephrology : JASN.

[23]  S. Mundra,et al.  Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis , 2009 .

[24]  KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  L. Schurgers,et al.  Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis , 2008, Circulation.

[26]  L. Hofbauer,et al.  The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  M. Litwin,et al.  Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  Z. Massy,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2008, Kidney international.

[29]  G. Hidalgo,et al.  Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease , 2008, Pediatric Nephrology.

[30]  T. Cole,et al.  A bimodal association of vitamin D levels and vascular disease in children on dialysis. , 2008, Journal of the American Society of Nephrology : JASN.

[31]  M. Mitsnefes.  Understanding carotid artery intima‐media thickness in childhood: Lessons from studies in children with renal transplants , 2008, Pediatric transplantation.

[32]  U. Berg,et al.  Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients * , 2008, Pediatric transplantation.

[33]  A. Freemont,et al.  Bone histomorphometry in children prior to commencing renal replacement therapy , 2008, Pediatric Nephrology.

[34]  L. Hofbauer,et al.  Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? , 2008, Kidney international.

[35]  C. McIntyre,et al.  Vascular Calcification Is Associated with Impaired Microcirculatory Function in Chronic Haemodialysis Patients , 2008, Nephron Clinical Practice.

[36]  L. Rees.  What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? , 2007, Pediatric Nephrology.

[37]  D. Milford,et al.  Mineral metabolism and vascular damage in children on dialysis. , 2007, Journal of the American Society of Nephrology : JASN.

[38]  W. Suki,et al.  Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. , 2007, Kidney international.

[39]  F. Dekker,et al.  High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  H. Oflaz,et al.  Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients , 2007, Pediatric Nephrology.

[41]  C. Shanahan,et al.  VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: The Vascular Biology of Calcification , 2007 .

[42]  Alex J. Brown,et al.  Vitamin D analogs for secondary hyperparathyroidism: What does the future hold? , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.

[44]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[45]  A. Levin,et al.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. , 2007, Kidney international.

[46]  I. Salusky.  A new era in phosphate binder therapy: what are the options? , 2006, Kidney international. Supplement.

[47]  E. Bedrick,et al.  Mortality risk among hemodialysis patients receiving different vitamin D analogs. , 2006, Kidney international.

[48]  Craig S. Wong,et al.  Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[49]  M. Budoff,et al.  Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. , 2006, Kidney international.

[50]  H. Oflaz,et al.  Coronary artery calcifications in children with end-stage renal disease , 2006, Pediatric Nephrology.

[51]  K. Wernecke,et al.  Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  G. Eknoyan,et al.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.

[53]  D. Haffner,et al.  A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  D. Goldsmith,et al.  Increased arterial stiffness in children on haemodialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[55]  C. McIntyre,et al.  Calcium exposure and removal in chronic hemodialysis patients. , 2006, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[56]  A. Levin,et al.  Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? , 2005, Kidney international.

[57]  M. Rossi,et al.  Left ventricular function and calcium phosphate plasma levels in uraemic patients , 2005, Journal of internal medicine.

[58]  J. Skepper,et al.  Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. , 2005, Journal of the American Society of Nephrology : JASN.

[59]  D. Geary,et al.  Home nocturnal hemodialysis in children. , 2005, The Journal of pediatrics.

[60]  S. Daniels,et al.  Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. , 2005, Journal of the American Society of Nephrology : JASN.

[61]  R. Elashoff,et al.  Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. , 2005, Journal of the American Society of Nephrology : JASN.

[62]  C. Reutelingsperger,et al.  Novel Conformation-Specific Antibodies Against Matrix γ-Carboxyglutamic Acid (Gla) Protein: Undercarboxylated Matrix Gla Protein as Marker for Vascular Calcification , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[63]  Anna Niemirska,et al.  Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[64]  P. Stenvinkel,et al.  Chronic kidney disease and inflammation in pediatric patients: from bench to playground , 2005, Pediatric Nephrology.

[65]  M. Mitsnefes,et al.  Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[66]  B. Kestenbaum,et al.  Serum phosphate levels and mortality risk among people with chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[67]  T. Drüeke.  Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means , 2005, Pediatric Nephrology.

[68]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[69]  S. Daniels,et al.  Abnormal Carotid Artery Structure and Function in Children and Adolescents With Successful Renal Transplantation , 2004, Circulation.

[70]  G. London,et al.  Arterial calcifications and bone histomorphometry in end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[71]  J. Craig,et al.  Long-term survival of children with end-stage renal disease. , 2004, The New England journal of medicine.

[72]  Christopher T. Chan,et al.  DAILY HEMODIALYSIS—SELECTED TOPICS: Cardiovascular Effects of Frequent Intensive Hemodialysis , 2004, Seminars in dialysis.

[73]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  C. Giachelli.  Vascular calcification: in vitro evidence for the role of inorganic phosphate. , 2003, Journal of the American Society of Nephrology : JASN.

[75]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[76]  M. Wolf,et al.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. , 2003, The New England journal of medicine.

[77]  C. Wanner,et al.  Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. , 2003, Kidney international. Supplement.

[78]  J. Blacher,et al.  Aortic pulse wave velocity index and mortality in end-stage renal disease. , 2003, Kidney international.

[79]  D. Batlle,et al.  Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. , 2003, Kidney international.

[80]  R. Selgas,et al.  Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. , 2003, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[81]  W. Stok,et al.  Increased arterial stiffness in young adults with end-stage renal disease since childhood. , 2002, Journal of the American Society of Nephrology : JASN.

[82]  R. Wolfe,et al.  Cardiovascular mortality in children and young adults with end-stage kidney disease. , 2002, The Journal of pediatrics.

[83]  A. Collins,et al.  Cardiovascular disease in pediatric chronic dialysis patients. , 2002, Kidney international.

[84]  M. Bahner,et al.  Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure , 2002, Circulation.

[85]  P. Raggi,et al.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. , 2002, Kidney international.

[86]  E. Krieger,et al.  Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[87]  H. Heymans,et al.  Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. , 2002, Kidney international.

[88]  K. Wu,et al.  Association of Hypertriglyceridemia and Insulin Resistance in UREMIC Patients Undergoing CAPD , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[89]  S. Daniels,et al.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors , 2000, Pediatric Nephrology.

[90]  J. Strong,et al.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[91]  J. Coresh,et al.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.

[92]  F. Port,et al.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[93]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[94]  D. Grönemeyer,et al.  Coronary artery calcifications in children and young adults treated with renal replacement therapy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[95]  P. Weissberg,et al.  Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. , 1999, Circulation.

[96]  T. Drüeke,et al.  Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. , 1999, Kidney international.

[97]  H. Mcgill,et al.  Determinants of atherosclerosis in the young , 1998 .

[98]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[99]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[100]  Y. Nishizawa,et al.  1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. , 1998, Circulation.

[101]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[102]  F. Port,et al.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[103]  P. Allhoff,et al.  Bogalusa Heart Study , 2020, Encyclopedia of Behavioral Medicine.

[104]  E. Maccarthy,et al.  1,25‐Dihydroxyvitamin D3 and Rat Vascular Smooth Muscle Cell Growth , 1989, Hypertension.